Dazodalibep Expands Horizons With Phase II Sjögren’s Syndrome Data

 
• By Alaric DeArment
  
Horizon unveiled positive Phase II data for dazodalibep in Sjögren’s syndrome • Source: Shutterstock

More from Immunological

More from Therapy Areas